---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-024623"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:59:17.405011+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Celularity retires all $41.6M senior secured debt via IP sale and license-back deal

## Summary
- Retired all $32M principal plus $9.6M accrued interest on senior secured loans for total $41.6M.
- Sold IP assets to Celeniv for $33,812,230; licensed back exclusively with five-year repurchase option.
- Created four operating subsidiaries for advanced biomaterials, longevity cell therapy, biobanking, and CDMO.
- Proceeds used to retire $27M RWI loan and $6,812,230 promissory note; prior note proceeds retired C.V. Starr loan.
- Retained exclusive use of IP; balance sheet improved with removal of general security interest.

## SEC filing metadata
- accession: 0001641172-25-024623
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000164117225024623/0001641172-25-024623-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000164117225024623/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-024623
- JSON: https://secwatch.observer/filing/0001641172-25-024623.json
- Plain text: https://secwatch.observer/filing/0001641172-25-024623.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.